NDA 21706, held by Santarus. Omeprazole; Sodium Bicarbonate.
As of Nov 14, 2026, NDA 21706 (Zegerid), held by Santarus, was first approved by FDA on Dec 21, 2004, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Dec 21, 2004 | Original applicationTYPE 6 · Standard review | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Zegerid40MG/PACKET;1.68GM/PACKET · for suspension; oral | Omeprazole; Sodium Bicarbonate | DiscontinuedReference drug |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters